121 related articles for article (PubMed ID: 37782184)
1. Clinical effectiveness of fluorouracil and cisplatin intraperitoneal perfusion combined with intravenous chemotherapy for peritoneal metastasis in gastric cancer.
Xiong XH; Mao QC; Yang JW; Chen SY; Li XQ
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8716-8731. PubMed ID: 37782184
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of postoperative intraperitoneal hyperthermic perfusion chemotherapy with oxaliplatin + 5-Fluorouracil in the treatment of gastric cancer patients with peritoneal carcinomatosis.
Yan K; Wu K; Yan L; Liang L; Yuan Y
J BUON; 2019; 24(4):1587-1594. PubMed ID: 31646813
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis.
Zhang S; Feng R; Pan Z; Lin M; Huang X; Jiang T; Xu Q; Chen Q; Yang S
Curr Pharm Biotechnol; 2018; 19(12):956-962. PubMed ID: 30426896
[TBL] [Abstract][Full Text] [Related]
4. [Safety and efficacy of intraperitoneal hyperthermic perfusion chemotherapy following laparoscopic palliative resection for gastric cancer patients with peritoneal metastasis].
Xia W; Hu Y; Mou T; Chen T; Yu J; Li G
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Nov; 17(11):1087-91. PubMed ID: 25421766
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
6. [Study of introperitoneal hyperthermic perfusion chemotherapy combined with systemic neoadjuvent chemotherapy in treatment of gastric cancer patients with peritoneal carcinomatosis].
Wang D; Xing Y; Guo Y; Zhang Y; Chen Y; Suo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):540-4. PubMed ID: 27215522
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intraperitoneal and intravenous chemotherapy for advanced gastric cancer with peritoneal metastasis.
Chen Y; Wang XJ; Lin RB; Chen L; Lin G; Guo ZQ
Tumori; 2014; 100(5):e180-8. PubMed ID: 25343556
[TBL] [Abstract][Full Text] [Related]
8. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma.
Zhibing W; Qinghua D; Shenglin M; Ke Z; Kan W; Xiadong L; Pengjun Z; Ruzhen Z
Hepatogastroenterology; 2013; 60(125):989-94. PubMed ID: 23598741
[TBL] [Abstract][Full Text] [Related]
10. Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
Ishigami H; Fujiwara Y; Fukushima R; Nashimoto A; Yabusaki H; Imano M; Imamoto H; Kodera Y; Uenosono Y; Amagai K; Kadowaki S; Miwa H; Yamaguchi H; Yamaguchi T; Miyaji T; Kitayama J
J Clin Oncol; 2018 Jul; 36(19):1922-1929. PubMed ID: 29746229
[TBL] [Abstract][Full Text] [Related]
11. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
Huang O; Lu X; Xu X; Shi Y
Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
[TBL] [Abstract][Full Text] [Related]
12. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
[No Abstract] [Full Text] [Related]
13. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
[TBL] [Abstract][Full Text] [Related]
14. Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106).
Shirao K; Boku N; Yamada Y; Yamaguchi K; Doi T; Goto M; Nasu J; Denda T; Hamamoto Y; Takashima A; Fukuda H; Ohtsu A;
Jpn J Clin Oncol; 2013 Oct; 43(10):972-80. PubMed ID: 24014884
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil.
Shimada S; Yagi Y; Kuramoto M; Aoki N; Ogawa M
Oncol Rep; 2003; 10(3):687-91. PubMed ID: 12684644
[TBL] [Abstract][Full Text] [Related]
16. [Report of case who survived more than five years after repeated intraperitoneal chemotherapy with cisplatin and 5-fluorouracil for treatment of macroscopically negative but microscopically positive peritoneal dissemination of gastric cancer].
Hiratsuka M; Furukawa H; Yasuda T; Murata K; Nakano H; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O; Imaoka S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1445-8. PubMed ID: 9703850
[TBL] [Abstract][Full Text] [Related]
17. First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer.
Iwasa S; Nakajima TE; Nakamura K; Takashima A; Kato K; Hamaguchi T; Yamada Y; Shimada Y
Gastric Cancer; 2012 Jan; 15(1):21-6. PubMed ID: 21573919
[TBL] [Abstract][Full Text] [Related]
18. [Effects of laparoscopic hyperthermic intraperitoneal perfusion chemotherapy combined with intraperitoneal and systemic chemotherapy treatment in patients with untreated gastric cancer with peritoneal metastasis].
Li S; Xue K; Dai HM; Wang YK; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):442-447. PubMed ID: 37217352
[No Abstract] [Full Text] [Related]
19. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW
Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148
[TBL] [Abstract][Full Text] [Related]
20. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
Kobayashi D; Ishigami H; Kanda M; Tanaka C; Yamaguchi H; Kitayama J; Kodera Y
Oncology; 2020; 98(1):48-52. PubMed ID: 31487733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
